| SURG (n = 32) | TACE (N = 16) | SIRT (N = 12) | P |
---|---|---|---|---|
Tumor differentiation | 0.51 | |||
 Well | 10 (31.2%) | 5 (31.2%) | 3 (25%) |  |
 Moderate | 18 (56.2%) | 10 (62.5%) | 6 (50%) |  |
 Poorly | 4 (12.5%) | 1 (6.25%) | 3 (25%) |  |
Tumor necrosis | < 0.001 | |||
 Absence | 26 (81.2%) | 1 (6.25%) | 3 (25%) |  |
 Minor (1–25%) | 4 (12.5%) | 2 (12.5%) | 1 (8.3%) |  |
 Moderate (25–50%) | 2 (6.25%) | 3 (18.75%) | 2 (16.6%) |  |
 Major (> 50%) | 0 | 5 (31.2%) | 4 (33.3%) |  |
 Complete (100%) | 0 | 5 (31.2%) | 2 (16.6%) |  |